Autism discovery paves way for early blood test and therapeutic options

Autism discovery paves way for early blood test and therapeutic options: The study, led by GGC's Director of Research, Charles Schwartz, PhD, (left) and Staff Scientist, Luigi Boccuto, MD, (right) found that individuals with autism spectrum disorders (ASDs) showed significantly decreased metabolism of the amino acid L-tryptophan when compared to both typical controls and individuals with other neurodevelopmental disorders. Cells from individuals with autism metabolized L-tryptophan at a decreased rate whereas cells from individuals without autism did not show this change.